FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012315536> ?p ?o ?g. }

• W2012315536 endingPage "3385" @default.
• W2012315536 startingPage "3368" @default.
• W2012315536 abstract "A novel class of heat shock protein 90 (Hsp90) inhibitors was discovered by high-throughput screening and was subsequently optimized using a combination of structure-based design, parallel synthesis, and the application of medicinal chemistry principles. Through this process, the biochemical and cell-based potency of the original HTS lead were substantially improved along with the corresponding metabolic stability properties. These efforts culminated with the identification of a development candidate (compound 42) which displayed desired PK/PD relationships, significant efficacy in a melanoma A2058 xenograft tumor model, and attractive DMPK profiles." @default.
• W2012315536 created "2016-06-24" @default.
• W2012315536 creator A5011697275 @default.
• W2012315536 creator A5014715629 @default.
• W2012315536 creator A5021102644 @default.
• W2012315536 creator A5021537878 @default.
• W2012315536 creator A5022936060 @default.
• W2012315536 creator A5023505029 @default.
• W2012315536 creator A5023836589 @default.
• W2012315536 creator A5031608383 @default.
• W2012315536 creator A5032921283 @default.
• W2012315536 creator A5039754491 @default.
• W2012315536 creator A5040346731 @default.
• W2012315536 creator A5043220708 @default.
• W2012315536 creator A5043280939 @default.
• W2012315536 creator A5045153459 @default.
• W2012315536 creator A5046508489 @default.
• W2012315536 creator A5046833171 @default.
• W2012315536 creator A5051851544 @default.
• W2012315536 creator A5061222029 @default.
• W2012315536 creator A5063140532 @default.
• W2012315536 creator A5063500857 @default.
• W2012315536 creator A5063873990 @default.
• W2012315536 creator A5067218552 @default.
• W2012315536 creator A5071409456 @default.
• W2012315536 creator A5071918899 @default.
• W2012315536 creator A5075130252 @default.
• W2012315536 creator A5079660804 @default.
• W2012315536 date "2011-04-20" @default.
• W2012315536 modified "2023-09-27" @default.
• W2012315536 title "Optimization of Potent, Selective, and Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors of Heat Shock Protein 90. Identification of Development Candidate 2-Amino-4-{4-chloro-2-[2-(4-fluoro-1<i>H</i>-pyrazol-1-yl)ethoxy]-6-methylphenyl}-<i>N</i>-(2,2-difluoropropyl)-5,7-dihydro-6<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxamide" @default.
• W2012315536 cites W1965787931 @default.
• W2012315536 cites W1966229978 @default.
• W2012315536 cites W1976692785 @default.
• W2012315536 cites W1978771408 @default.
• W2012315536 cites W1986805238 @default.
• W2012315536 cites W1990520277 @default.
• W2012315536 cites W1991514105 @default.
• W2012315536 cites W1999715990 @default.
• W2012315536 cites W2003403912 @default.
• W2012315536 cites W2008525757 @default.
• W2012315536 cites W2022738428 @default.
• W2012315536 cites W2032733419 @default.
• W2012315536 cites W2033706352 @default.
• W2012315536 cites W2033784113 @default.
• W2012315536 cites W2043892875 @default.
• W2012315536 cites W2047782251 @default.
• W2012315536 cites W2053617159 @default.
• W2012315536 cites W2062458432 @default.
• W2012315536 cites W2072008056 @default.
• W2012315536 cites W2074579328 @default.
• W2012315536 cites W2082390299 @default.
• W2012315536 cites W2082474121 @default.
• W2012315536 cites W2111187586 @default.
• W2012315536 cites W2117807601 @default.
• W2012315536 cites W2123158115 @default.
• W2012315536 cites W2125634299 @default.
• W2012315536 cites W2140937615 @default.
• W2012315536 cites W2165088901 @default.
• W2012315536 cites W2165711991 @default.
• W2012315536 cites W2978691901 @default.
• W2012315536 doi "https://doi.org/10.1021/jm200128m" @default.
• W2012315536 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21438541" @default.
• W2012315536 hasPublicationYear "2011" @default.
• W2012315536 type Work @default.
• W2012315536 sameAs 2012315536 @default.
• W2012315536 citedByCount "36" @default.
• W2012315536 countsByYear W20123155362012 @default.
• W2012315536 countsByYear W20123155362013 @default.
• W2012315536 countsByYear W20123155362014 @default.
• W2012315536 countsByYear W20123155362015 @default.
• W2012315536 countsByYear W20123155362016 @default.
• W2012315536 countsByYear W20123155362017 @default.
• W2012315536 countsByYear W20123155362018 @default.
• W2012315536 countsByYear W20123155362019 @default.
• W2012315536 countsByYear W20123155362020 @default.
• W2012315536 countsByYear W20123155362021 @default.
• W2012315536 countsByYear W20123155362022 @default.
• W2012315536 countsByYear W20123155362023 @default.
• W2012315536 crossrefType "journal-article" @default.
• W2012315536 hasAuthorship W2012315536A5011697275 @default.
• W2012315536 hasAuthorship W2012315536A5014715629 @default.
• W2012315536 hasAuthorship W2012315536A5021102644 @default.
• W2012315536 hasAuthorship W2012315536A5021537878 @default.
• W2012315536 hasAuthorship W2012315536A5022936060 @default.
• W2012315536 hasAuthorship W2012315536A5023505029 @default.
• W2012315536 hasAuthorship W2012315536A5023836589 @default.
• W2012315536 hasAuthorship W2012315536A5031608383 @default.
• W2012315536 hasAuthorship W2012315536A5032921283 @default.
• W2012315536 hasAuthorship W2012315536A5039754491 @default.
• W2012315536 hasAuthorship W2012315536A5040346731 @default.
• W2012315536 hasAuthorship W2012315536A5043220708 @default.
• W2012315536 hasAuthorship W2012315536A5043280939 @default.
• W2012315536 hasAuthorship W2012315536A5045153459 @default.
• W2012315536 hasAuthorship W2012315536A5046508489 @default.
• W2012315536 hasAuthorship W2012315536A5046833171 @default.
• W2012315536 hasAuthorship W2012315536A5051851544 @default.
• W2012315536 hasAuthorship W2012315536A5061222029 @default.

• next